- This event has passed.
Symposium: Psoriasis: What We Have Learned and Where We Are Going
Agenda
PART ONE: LECTURES
Welcome and Introduction
Lars Iversen
Psoriasis in the Last Millennium
Peter van de Kerkhof
Psoriasis and Genetics
Jonathan Barker
Psoriasis and the Immune System
Georg Stingl
Current and Novel Treatments
Filip Rob
Biomarkers in Psoriasis Treatment – Today and in the Future
Lone Skov
Non-pharmacological Management Today and in the Future
Alexander Navarini
Long-term Remission, Inflammatory Memory & Disease Modification
Curdin Conrad
Panel Discussion
All faculty
BREAK
PART TWO: POSTER PRESENTATIONS
Blocking Interleukin-17 in Psoriasis: Real-world Experience from the PsoPlus Cohort
Lisa Schots – Ghent University Hospital, Ghent, Belgium
IL-17A+ Mast Cells in Resolved Psoriasis
Theresa Benezeder – Medical University of Graz, Graz, Austria
Genomic and Epigenomic Rofiling of “Invisible Scar” in Psoriatic Resolved Skin
Ameneh Ghaffarinia – Skin Research Group, Szeged, Hungary
Pathogenic Relationship between Psoriasis and Obesity: An Ex Vivo Study
Giulia Briatico – University of Campania, Napoli, Campania, Italy
Using Single-Cell Transcriptomics to Characterise Early Mechanisms of Disease Remission in Psoriasis
Luc Francis – St. John’s Institute of Dermatology, London, England, United Kingdom
Cytokine Imbalance During Targeted Therapies for Psoriasis and Atopic Dermatitis – The Yin Yang of Th17 and Th2
Francesco Messina – University Hospital CHUV, Lausanne, Switzerland
Defining Paradoxical Psoriasis and Deep Tissue Immune Cell Profiling
David Croitoru – University of Toronto, Toronto, Ontario, Canada
ADJOURN
Program Chair
Program Faculty
Christopher Griffiths, OBE, MD, FRCP, FMedSci
University of Manchester
Manchester, United Kingdom
Honorary Founder
Bio
Lone Skov, MD, PhD
Herlev and Gentofte Hospital, University of Copenhagen
Hellerup, Denmark
IPC Board Member
Bio
You must be registered for ESDR to attend the IPC symposium.
